Sarepta Therapeutics | 10-Q: Quarterly report
May 2 04:07
Sarepta Therapeutics | DEF 14A: Definitive information statements
Apr 25 04:11
Sarepta Therapeutics | ARS: Annual Report to Security Holders
Apr 25 04:05
Sarepta Therapeutics | DEFA14A: Others
Apr 25 04:05
Sarepta Therapeutics | S-8 POS: S-8 POS
Mar 29 10:33
Sarepta Therapeutics | S-8 POS: S-8 POS
Mar 29 10:33
Sarepta Therapeutics | S-8 POS: S-8 POS
Mar 29 04:25
Sarepta Therapeutics | S-8 POS: S-8 POS
Mar 29 04:18
Sarepta Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Wigzell Hans Lennart Rudolf
Mar 12 08:03
Sarepta Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Arif Bilal
Mar 12 08:03
Sarepta Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Rodino-Klapac Louise
Mar 12 08:03
Sarepta Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Boor Kathryn Jean
Mar 12 08:03
Sarepta Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Brown Ryan Edward
Mar 12 08:03
Sarepta Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Estepan Ian Michael
Mar 12 08:03
Sarepta Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Mar 12 07:08
Sarepta Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Mar 9 06:41
Sarepta Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Estepan Ian Michael
Mar 7 09:05
Sarepta Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Mayo Stephen
Mar 7 09:05
Sarepta Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Brown Ryan Edward
Mar 7 09:05
Sarepta Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Arif Bilal
Mar 7 09:05
No Data
No Data